Androderm and Temaz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Androderm and Temaz. Common interactions include depression among males.

The phase IV clinical study analyzes what interactions people who take Androderm and Temaz have. It is created by eHealthMe based on reports of 23 people who take Androderm and Temaz from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 03, 2023

23 people who take Androderm and Temaz together, and have interactions are studied.

What is Androderm?

Androderm has active ingredients of testosterone. It is often used in testosterone. eHealthMe is studying from 3,953 Androderm users for its effectiveness, alternative drugs and more.

What is Temaz?

Temaz has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 38,821 Temaz users for its effectiveness, alternative drugs and more.

Number of Androderm and Temaz reports submitted per year:

Common Androderm and Temaz drug interactions by gender *:

female:

n/a

male:

Depression
Anxiety
Cardiac disorder
Cardiac failure congestive
Chest pain
Disturbance in attention
Peripheral swelling
Platelet count decreased
Pneumonia
Pneumonia aspiration

Common Androderm and Temaz drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Memory impairment

30-39:

n/a

40-49:

Activities of daily living impaired
Akathisia
Dyskinesia
Dystonia
Emotional disorder
Extrapyramidal disorder
Gait disturbance
Muscular weakness
Neck pain
Speech disorder

50-59:

Anxiety
Depression
Pancreatic carcinoma metastatic
Acute respiratory failure
Adenocarcinoma pancreas
Asthenia
Cardiac failure congestive
Chest pain
Disturbance in attention
Peripheral swelling

60+:

Epistaxis
Pericardial haemorrhage
Multiple myeloma
Pain
Pathological fracture
Platelet count decreased
Pulmonary embolism
Thrombocytosis
Bacteraemia
Blood creatinine increased

Common conditions people have *:

Type 2 Diabetes: 5 people, 21.74%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 21.74%
Depression: 5 people, 21.74%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 21.74%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 4 people, 17.39%
Pulmonary Embolism (blockage of the main artery of the lung): 4 people, 17.39%
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble): 4 people, 17.39%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 17.39%
Pain: 3 people, 13.04%
Primary Myelofibrosis (primary disorder of the bone marrow): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Androderm and Temaz?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.